232 related articles for article (PubMed ID: 27236079)
1. Lessons from crystal structures of kainate receptors.
Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
Neuropharmacology; 2017 Jan; 112(Pt A):16-28. PubMed ID: 27236079
[TBL] [Abstract][Full Text] [Related]
2. A pharmacological profile of the high-affinity GluK5 kainate receptor.
Møllerud S; Kastrup JS; Pickering DS
Eur J Pharmacol; 2016 Oct; 788():315-320. PubMed ID: 27373850
[TBL] [Abstract][Full Text] [Related]
3. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
[TBL] [Abstract][Full Text] [Related]
4. Binding site and interlobe interactions of the ionotropic glutamate receptor GluK3 ligand binding domain revealed by high resolution crystal structure in complex with (S)-glutamate.
Venskutonytė R; Frydenvang K; Gajhede M; Bunch L; Pickering DS; Kastrup JS
J Struct Biol; 2011 Dec; 176(3):307-14. PubMed ID: 21907808
[TBL] [Abstract][Full Text] [Related]
5. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M
J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069
[TBL] [Abstract][Full Text] [Related]
6. Kainate induces various domain closures in AMPA and kainate receptors.
Venskutonytė R; Frydenvang K; Hald H; Rabassa AC; Gajhede M; Ahring PK; Kastrup JS
Neurochem Int; 2012 Sep; 61(4):536-45. PubMed ID: 22425692
[TBL] [Abstract][Full Text] [Related]
7. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
[TBL] [Abstract][Full Text] [Related]
8. Structural and pharmacological characterization of phenylalanine-based AMPA receptor antagonists at kainate receptors.
Venskutonytė R; Frydenvang K; Valadés EA; Szymańska E; Johansen TN; Kastrup JS; Pickering DS
ChemMedChem; 2012 Oct; 7(10):1793-8. PubMed ID: 22407805
[TBL] [Abstract][Full Text] [Related]
9. Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.
Fisher JL; Housley PR
Cell Mol Neurobiol; 2013 Nov; 33(8):1099-108. PubMed ID: 23975096
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.
Mayer ML
Neuron; 2005 Feb; 45(4):539-52. PubMed ID: 15721240
[TBL] [Abstract][Full Text] [Related]
11. Kainate receptor channel opening and gating mechanism.
Gangwar SP; Yelshanskaya MV; Nadezhdin KD; Yen LY; Newton TP; Aktolun M; Kurnikova MG; Sobolevsky AI
Nature; 2024 Jun; 630(8017):762-768. PubMed ID: 38778115
[TBL] [Abstract][Full Text] [Related]
12. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine.
Frydenvang K; Lash LL; Naur P; Postila PA; Pickering DS; Smith CM; Gajhede M; Sasaki M; Sakai R; Pentikaïnen OT; Swanson GT; Kastrup JS
J Biol Chem; 2009 May; 284(21):14219-29. PubMed ID: 19297335
[TBL] [Abstract][Full Text] [Related]
13. The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit.
Fisher JL
Neuropharmacology; 2014 Oct; 85():9-17. PubMed ID: 24859608
[TBL] [Abstract][Full Text] [Related]
14. The Structure of a High-Affinity Kainate Receptor: GluK4 Ligand-Binding Domain Crystallized with Kainate.
Kristensen O; Kristensen LB; Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
Structure; 2016 Sep; 24(9):1582-9. PubMed ID: 27524200
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.
Lash-Van Wyhe LL; Postila PA; Tsubone K; Sasaki M; Pentikäinen OT; Sakai R; Swanson GT
Neuropharmacology; 2010 Mar; 58(3):640-9. PubMed ID: 19962997
[TBL] [Abstract][Full Text] [Related]
16. Assembly and Trafficking of Homomeric and Heteromeric Kainate Receptors with Impaired Ligand Binding Sites.
Scholefield CL; Atlason PT; Jane DE; Molnár E
Neurochem Res; 2019 Mar; 44(3):585-599. PubMed ID: 30302614
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and structural characterization of conformationally restricted (S)-glutamate analogues at ionotropic glutamate receptors.
Juknaitė L; Venskutonytė R; Assaf Z; Faure S; Gefflaut T; Aitken DJ; Nielsen B; Gajhede M; Kastrup JS; Bunch L; Frydenvang K; Pickering DS
J Struct Biol; 2012 Oct; 180(1):39-46. PubMed ID: 22789682
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
Mayer ML; Ghosal A; Dolman NP; Jane DE
J Neurosci; 2006 Mar; 26(11):2852-61. PubMed ID: 16540562
[TBL] [Abstract][Full Text] [Related]
19. Domain organization and function in GluK2 subtype kainate receptors.
Das U; Kumar J; Mayer ML; Plested AJ
Proc Natl Acad Sci U S A; 2010 May; 107(18):8463-8. PubMed ID: 20404149
[TBL] [Abstract][Full Text] [Related]
20. The structural arrangement and dynamics of the heteromeric GluK2/GluK5 kainate receptor as determined by smFRET.
Litwin DB; Paudyal N; Carrillo E; Berka V; Jayaraman V
Biochim Biophys Acta Biomembr; 2020 Jan; 1862(1):183001. PubMed ID: 31194959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
